RPRX

39.16

1.43% -0.57

Handel nachbörslich: 39.16

Royalty Pharma Plc (RPRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$39.73

Offen:

$39.42

24-Stunden-Volumen:

2.57M

Relative Volume:

0.63

Marktkapitalisierung:

$16.93B

Einnahmen:

$2.31B

Nettoeinkommen (Verlust:

$1.66B

KGV:

17.05

EPS:

2.297

Netto-Cashflow:

$827.02M

1W Leistung:

+1.56%

1M Leistung:

+8.78%

6M Leistung:

+21.28%

1J Leistung:

+53.09%

1-Tages-Spanne:

$38.82

$39.65

1-Wochen-Bereich:

$38.39

$40.01

52-Wochen-Spanne:

$24.05

$41.24

Royalty Pharma Plc Stock (RPRX) Company Profile

Firmenname

Royalty Pharma Plc

Sektor

Healthcare (1135)

Branche

Biotechnology (634)

Telefon

(212) 883-0200

Adresse

110 EAST 59TH STREET, NEW YORK, NY

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-02-11

Neueste SEC-Einreichungen

RPRX's Discussions on Twitter

Vergleichen Sie RPRX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RPRX Royalty Pharma Plc	39.16	16.97B	2.31B	1.66B	827.02M	2.297
VRTX Vertex Pharmaceuticals Inc	437.15	110.25B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	693.50	73.04B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	449.16	59.98B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	907.98	54.90B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	193.22	40.73B	447.02M	-1.18B	-906.14M	-6.1812

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-30	Eingeleitet	Goldman	Buy
2025-05-16	Eingeleitet	Morgan Stanley	Overweight
2024-06-03	Herabstufung	UBS	Buy → Neutral
2022-06-14	Fortgesetzt	UBS	Buy
2022-05-13	Eingeleitet	Scotiabank	Sector Outperform
2022-04-27	Eingeleitet	Goldman	Buy
2022-04-14	Hochstufung	JP Morgan	Neutral → Overweight
2022-04-06	Fortgesetzt	Morgan Stanley	Overweight
2021-10-29	Hochstufung	Citigroup	Neutral → Buy
2021-07-30	Eingeleitet	Tigress Financial	Buy
2020-11-09	Hochstufung	UBS	Neutral → Buy
2020-07-14	Eingeleitet	Evercore ISI	In-line
2020-07-13	Eingeleitet	BofA Securities	Buy
2020-07-13	Eingeleitet	Citigroup	Neutral
2020-07-13	Eingeleitet	Cowen	Outperform
2020-07-13	Eingeleitet	Goldman	Neutral
2020-07-13	Eingeleitet	JP Morgan	Neutral
2020-07-13	Eingeleitet	Morgan Stanley	Equal-Weight
2020-07-13	Eingeleitet	SunTrust	Buy
2020-07-13	Eingeleitet	UBS	Neutral

Alle ansehen

Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten

Nov 15, 2025

Why analysts remain bullish on Royalty Pharma plc stockForecast Cut & AI Forecast Swing Trade Picks - newser.com

Nov 15, 2025

Is Royalty Pharma plc stock a safe investment in uncertain marketsWeekly Loss Report & Long-Term Capital Growth Strategies - newser.com

Nov 15, 2025

Applying chart zones and confluence areas to Royalty Pharma plcInsider Selling & Free Daily Entry Point Trade Alerts - newser.com

Nov 15, 2025

Is Royalty Pharma Plc's (NASDAQ:RPRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - 富途牛牛

Nov 15, 2025

Royalty Pharma: Guidance Raised Again, Platform Strength Intact -- Buy Reiterated (NASDAQ:RPRX) - Seeking Alpha

Nov 15, 2025

Historical volatility pattern of Royalty Pharma plc visualizedEarnings Recap Report & Daily Market Momentum Tracking - newser.com

Nov 15, 2025

Is Royalty Pharma plc (RPD) stock attractive post correctionJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com

Nov 15, 2025

Will Royalty Pharma plc (RPD) stock hit Wall Street targets2025 Price Momentum & AI Enhanced Trading Alerts - newser.com

Nov 15, 2025

Top chart patterns to watch in Royalty Pharma plc2025 Technical Overview & Daily Stock Trend Watchlist - newser.com

Nov 15, 2025

Nov 14, 2025

Why retail investors pile into Royalty Pharma plc stockWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com

Nov 14, 2025

Is Royalty Pharma plc (RPD) stock a buy during volatile marketsVolume Spike & Verified Chart Pattern Signals - newser.com

Nov 14, 2025

Monetta Financial Services Inc. Acquires New Shares in Royalty Pharma PLC $RPRX - MarketBeat

Nov 14, 2025

What drives Royalty Pharma plc stock priceResistance Breakout Alerts & Accelerated Capital Growth - earlytimes.in

Nov 14, 2025

How Royalty Pharma plc (RPD) stock performs in easing cyclesEarnings Growth Report & Community Trade Idea Sharing - newser.com

Nov 14, 2025

Mitsubishi UFJ Trust & Banking Corp Lowers Position in Royalty Pharma PLC $RPRX - MarketBeat

Nov 14, 2025

Analyzing net buyer seller activity in Royalty Pharma plcWeekly Stock Summary & Consistent Growth Equity Picks - newser.com

Nov 14, 2025

Nov 13, 2025

Will Royalty Pharma plc (RPD) stock maintain strong growthRisk Management & Weekly High Return Stock Opportunities - newser.com

Nov 13, 2025

What’s the recovery path for long term holders of Royalty Pharma plcWeekly Loss Report & Consistent Return Investment Signals - newser.com

Nov 13, 2025

Can Royalty Pharma plc stock rebound after recent weaknessShare Buyback & Daily Oversold Bounce Ideas - newser.com

Nov 13, 2025

Jupiter Asset Management Ltd. Acquires 1,380,115 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Nov 13, 2025

Nov 12, 2025

Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance

Nov 12, 2025

Is Royalty Pharma plc reversing from oversold territoryWeekly Volume Report & Step-by-Step Swing Trade Plans - newser.com

Nov 12, 2025

Ex-Dividend Reminder: Royalty Pharma, Cencora and MMM - Nasdaq

Nov 12, 2025

Bank of New York Mellon Corp Lowers Holdings in Royalty Pharma PLC $RPRX - MarketBeat

Nov 12, 2025